As of today (2024-04-23), ICU Medical's share price is $97.76.
ICU Medical's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $3.00. Hence, ICU Medical's Price-to-Free-Cash-Flow Ratio for today is 32.55.
The historical rank and industry rank for ICU Medical's Price-to-Free-Cash-Flow or its related term are showing as below:
ICUI'
s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 17.74 Med: 33.63 Max: 4922.12
Current: 32.59
During the past 13 years, ICU Medical's highest Price-to-Free-Cash-Flow Ratio was 4922.12. The lowest was 17.74. And the median was 33.63.
ICUI's Price-to-Free-Cash-Flow is ranked worse than 51.64% of 335
companies
in the Medical Devices & Instruments industry
Industry Median: 31.24
vs ICUI: 32.59
During the past 3 years, the average Free Cash Flow per Share Growth Rate was -19.00% per year.
During the past 13 years, ICU Medical's highest 3-Year average Free Cash Flow per Share Growth Rate was 174.30% per year. The lowest was -228.40% per year. And the median was 4.80% per year.
ICU Medical Price-to-Free-Cash-Flow Historical Data
The historical data trend for ICU Medical's Price-to-Free-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, ICU Medical's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ICU Medical Price-to-Free-Cash-Flow Distribution
For the Medical Devices & Instruments industry and Healthcare sector, ICU Medical's Price-to-Free-Cash-Flow distribution charts can be found below:
* The bar in red indicates where ICU Medical's Price-to-Free-Cash-Flow falls into.
ICU Medical Price-to-Free-Cash-Flow Calculation
ICU Medical's Price-to-Free-Cash-Flow ratio for today is calculated as
ICU Medical's Share Price of today is $97.76.
ICU Medical's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
ICU Medical (NAS:ICUI) Price-to-Free-Cash-Flow Explanation
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
Be Aware
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
ICU Medical Price-to-Free-Cash-Flow Related Terms
Thank you for viewing the detailed overview of ICU Medical's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
ICU Medical is a California-based, pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017, and Smiths Medical from Smiths Group in 2022. It holds top-tier positions in its original reporting segments: infusion consumables (25% of 2022 revenue), IV solutions (16%), infusion systems (15%), and critical care (2%) as well as its new Smiths segments: Smiths infusion systems (15%), vascular access (14%), and vital care (12%). The combined entity remains primarily U.S. focused, generating over 64% of its sales domestically.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ICUI has been successfully added to your 